Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA requests more data for Protalix's taliglucerase alfa NDA

March 1, 2011

New glucokinase activators reported by Zydus-Cadila

March 1, 2011

New 11-beta-HSD1 inhibitors patented at sanofi-aventis

March 1, 2011

Novel acyl-CoA desaturase inhibitors discovered at Pierre Fabre

March 1, 2011

Enrollment complete in first of two pivotal phase III efficacy trials of LibiGel

Feb. 28, 2011

NV Organon patents new glycoprotein hormone FSH receptor agonists

Feb. 25, 2011

FDA approves label update for Onglyza

Feb. 25, 2011

Endpoints met in phase Ib trial of TransPharma's ViaDor-GLP-1 agonist in type 2 diabetes

Feb. 25, 2011

Japanese approval granted for Sosei's NorLevo emergency contraceptive pill

Feb. 24, 2011

Stamford Hospital participates in FDA's Expanded Access program for Generex Oral-lyn

Feb. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.